Henry Meds

Henry Meds (operating at henrymeds.com) is a telehealth and subscription-based healthcare platform engineered for accessible, personalized medical care. Founded in 2022 and headquartered in Dover, Delaware, Henry Meds redefines how individuals manage weight loss, hormone therapy, and sexual health—solving the barriers of cost, convenience, and stigma tied to traditional healthcare. Under the hood, the platform combines virtual consultations with compounded medications, GLP-1 treatments, and endocrine care, all delivered via a seamless online experience. This allows patients to receive tailored, evidence-based solutions without the need for in-person visits or exorbitant out-of-pocket expenses. Backed by a $2.2 million total funding round, including a $16 million Series A led by BlackRock and Fin Capital, Henry Meds is positioned to scale its mission of democratizing specialized medical care.